5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylim

Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – X-ray contrast imaging agent

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

564153, C07C23568

Patent

active

054646073

ABSTRACT:
##STR1## wherein R, R', R.sub.1, and R.sub.1 ', which are the same or different, are H, C.sub.1 -C.sub.4 alkyl, linear or branched C.sub.1 -C.sub.4 mono- or polyhydroxyalkyl;
R.sub.2, R.sub.2 ', R.sub.3, and R.sub.3 ', which are the same or different, are one of the groups of formula --CH.sub.2 CH.sub.2 OH, --CH.sub.2 CH(OH) CH.sub.2 OH --CH(CH.sub.2 OH)CH(OH)CH.sub.2 OH, --CH.sub.2 (CHOH).sub.4 CH.sub.2 OH, or --CH(CH.sub.2 OH).sub.2 ; and X is one of the groups --CH(OH)--, --CH(CH.sub.2 OH)--, --C(OH) (CH.sub.2 OH)--, or --C(CH.sub.2 OH).sub.2 --, are useful as opacifying components for X-ray contrast media.

REFERENCES:
patent: 3632738 (1972-01-01), Ingelman et al.
patent: 4014986 (1977-03-01), Tilly et al.
patent: 4239747 (1980-12-01), Pfeiffer et al.
patent: 4264572 (1981-04-01), Klieger et al.
patent: 4348377 (1982-09-01), Felder et al.
patent: 4367216 (1983-01-01), Mutzel et al.
patent: 5004835 (1991-04-01), Blaszkiewicz et al.
patent: 5349085 (1994-09-01), Hansen et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylim does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylim, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5,5'-/(1,3-propanediyl) bis-/imino(2-oxo-2,1-ethanediyl)acetylim will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-195666

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.